Urinary leukotriene E4 during specific bronchial challenge testing in occupational asthma Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006
Clinical efficacy of leukotriene antagonist in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005
To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Comparison of nasal steroids, antileukotrienes and combination therapy in seasonal allergic rhinitis: effect on exhaled breath markers Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003
Prostaglandin E2 levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma Source: Eur Respir J 2004; 24: 226-230 Year: 2004
Aspirin significantly decreases urinary leukotriene E4 concentration in aspirin-tolerant asthma patients who show hyperleukotrienuria in stable condition Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
Cost-minimisation analysis of two different inhaled steroids in persistent bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 302s Year: 2002
Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
A comparative analysis of the non-specific bronchial hyperreactivity in patients with newly discovered bronchial asthma combined with allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 235s Year: 2006
The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002
Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 121s Year: 2006
Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018
Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
Zafirlucast influence on interleukin-2 in children with moderate bronchial asthma after cancellation of inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 122s Year: 2001
Measurement of leukotrienes urinary excretion in patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
Correlations of QOL questionnaire results and effects of leukotriene receptor antagonist in asthma and allergic rhinitis Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006
The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Source: Eur Respir J 2002; 20: 1364-1369 Year: 2002
Detection of genetic alterations in nasal aspirates from COPD, asthmatic and allergic rhinitis patients: preliminary results Source: Eur Respir J 2005; 26: Suppl. 49, 483s Year: 2005